Introduction
A state of low serum sodium had been seen to occur frequently during the course of their illness in patients with acute mveloid leukaemia and its variants. This paper presents pertinent data on 14 patients together with balance studies on two of these in whom hyponatraemia developed as the result of unexplained sodium wasting from the kidney.
Patients and Methods
To investigate the electrolyte disturbances often seen in association with acute leukaemia, Na and K balance studies were conducted on all newly-admitted patients with acute myeloid leukaemia These studies were generally limited to a five-day period covering each admission and readmission to hospital. This study concerns 14 consecutive patients who were investigated in this manner. Two of these (cases 2 and 4, see below) were investigated intensively throughout the period of their stay in hospital. The effects of saline and fluid loads were studied in these two patients (figs. 1 and 2). The values of dietary Na, K, and nitrogen were calculated by the method of McCance and Widdowson (1969) . Food eaten was accounted for in the final analysis of these values.
Twenty-four-hour urine collections beginning at 8 a.m. each day were made, using chloroform as preservative. Blood samples were obtained and analysed on the same day. Body weight was measured after voiding. The measurements of Na and K were carried out with a flame photometer and those of urea and chloride in a Technicon AutoAnalyzer. Osmolality of serum and urine was determined by advanced osmometer. However, in case 4 on days 1, 2, 5, and 12 ( fig. 2 ) osmolality of urine was estimated indirectly-that is 2 (Na + K) + Urea mg/l. Mol. Wt. of urea (= 60) Plasma cortisol was determined fluorometrically (Mattingly et al., 1964) and serum thyroxine by the T-4 column test (Biorad Co.) . Plasma arginine vasopressin was determined by radioimmunoassay (Beardwell, 1971 The hvponatraemia continued throughout the period of the study ( fig. 2 ) despite the withdrawal of chlorpropamide. The blood urea dropped to 12 mg/ 100 ml. He was discharged 17 days after admission. He was readmitted on two more occasions and found to have a low serum Na concentration which returned to normal on each occasion when his oral intake of fluids was restricted to less than 2 1./day.
Results
Hyponatraemia (serum Na <135 mEq/l.) developed in 11 of the 14 patients (78%). Three of these 11 patients (cases 4, 10, and 12) had a low serum Na level on admission before any cytotoxic therapy had been initiated (table I) . One (case 4) was taking chlorpropamide and prednisolone (see Case Report) but the other two patients had not received drugs before the development of hyponatraemia. Two other patients (cases 7 and 9) had serum Na levels in the lower range of normal (table I) before any treatment had been started, and these levels dropped further after induction therapy. Four of these five patients had a high absolute blast cell count. The remaining six patients developed hyponatraemia after antileukaemic therapy. In each of these six cases a considerable fall in the blast cell count (bone marrow and peripheral blood) coincided with a fall in the serum Na level ( seen to occur in association with a fall in the blast cell count in all patients who received cytotoxic therapy.
Sodium Balance Studies.-Patients were allowed a sodium intake of 60-85m Eq/day. Variations in either direction occurred as a result of poor appetite and intravenous therapy. Pretreatment urine collection was incomplete in three patients but urinary Na values were obtained in the other 11 before induction therapy (table II) . Seven of these patients were in positive Na balance but their urinary sodium excretion increased appreciably during induction therapy. The pretreatment urinary excretion of Na was high in three patients and this remained raised during antileukaemic therapy (table II) . It is noteworthy that these three patients with a significant natriuresis were on high doses of prednisolone (table I ). An increase in salt intake led to a further loss of Na in urine in all the 14 patients (table II) without any significant improvement in the serum Na level (see figs. 1 and 2).
Urine and Serum Osmolality.-The urine was found to be consistently hypertonic to the serum at the onset of hyponatraemia in all the 11 patients (table II) .
Effects of Variation in Fluid and Sodium Intake.-Two patients (cases 2 and 4) were investigated in some depth in order to study the effects of alteration of salt and fluid intake. Both were febrile throughout the period of the study and were allowed free access to fluids. One (case 4) drank copiously and his intake, including intravenous fluids, ranged between 4 and 6 1./day. A severe reduction to below 2 1./day corrected hyponatraemia on two occasions. The other patient maintained a fluid intake of from 2 to 3 l./day. Her water intake was reduced to 800 ml/24 hr on the 19th day of the study. This led to a fall in the urinary output and the serum Na increased to 137 mEq/l. (fig. 1 ). The saline load was increased on days 6 to 9 in case 2. Diuresis ensued with a fall in the urine osmolality ( fig. 1) . The body weight increased by 2 kg. Sodium intake was increased on days 12 and 17. This aggravated the salt loss in the urine and the serum Na level fell to its lowest level of 118 mEq/l. on day 12. Similar results were obtained in case 4. The increased Na intake was promptly passed in the urine giving an overall negative Na balance ( fig. 2) . The first step in the chain of events in these two patients was an increase in the urinary Na excretion, and this increased further after an increased salt intake with only a transient improvement in the serum Na level. Both patients failed to excrete osmoticallyfree water and elaborated urine inappropriately hypertonic to the serum. A severe restriction in the fluid intake led to an increase in the serum Na level.
Other Studies.-The plasma arginine vasopressin level was found to range between 0 7 and 1-8 pg/ml in three patients (cases 1, 2, and 12) at the height of their hyponatraemia. These values are considered to be at the lower limit of the normal range. (C. G. Beardwell, personal communication, 1973) .
Plasma cortisol was determined at 10 a.m. on two consecutive days in 11 patients and the average of the two values is shown in table III. There was no adrenal or thyroid insufficiency as determined by plasma cortisol and T-4 column iodine levels (table III) . One patient (case 13) was on L-thyroxine because of previously diagnosed hypothyroidism, but this appeared to be Normal range (6 subjects)
2-3-6-1 10-30 well controlled with treatment and the patient showed no clinical or laboratory evidence of thyroid deficiency. Renal function as determined by creatinine clearance estimations, urine analysis, and blood urea levels was found to be adequate at the onset of hyponatraemia in all patients. Blood urea levels fell with the development of hyponatraemia in all patients and values below 15 mg/100 ml were observed in four patients (cases 1-4).
Discussion
The low serum Na state did not appear to be related to therapy in two patients (cases 10 and 12) who developed hyponatraemia before any treatment had been started (table I) . One patient (case 4) had been on chlorpropamide and prednisolone before the development of hyponatraemia. Chlorpropamide therapy has been found to induce fluid retention and hyponatraemia but the syndrome abates after withdrawal of the drug (Fine and Shedrovilzky, 1970, Weissman et al., 1971 (Spittle, 1966) , so far as we are aware acute leukaemia has not been known to be associated with this syndrome. It appears unlikely that the low serum Na state in these patients was due to an excess of antidiuretic hormone since plasma arginine vasopressin levels were found to be normal in three patients with the syndrome. The data available here favour the conclusion that this syndrome of hyponatraemia was induced by a natriuretic substance which was not antidiuretic hormone but resembled it in most of its actions. The most prominent feature in seven of the 11 patients was an increase of natriuresis after the administration of cytotoxic therapy with a consequent fall in the serum Na level (tables I and II). The three patients excreting large quantities of Na before induction therapy were taking high doses of prednisolone. It was a paradoxical phenomenon since corticosteroids are well known for their saltretaining effect (Lange and Doorenbos, 1972) . Occasionally hypernatraemia has been observed to develop after the administration of pharmacological doses of corticosteroids (Sawyer et al., 1967) . It is possible that this phenomenon of natriuresis associated with the administration of prednisolone in these three patients may have had the same basis as the augmented natriuresis induced by cytotoxic therapy in the other seven patients. Corticosteroids have non-specific antileukaemic properties and have been reported to induce remission in a significant proportion of patients with acute leukaemia (Fessas et al., 1954; Sampey, 1963 The concept that primitive cells of the myeloid series secrete a natriuretic substance is not an exaggeration of the functional scope of these cells. Leucocytes are thought to produce a significant portion of vitamin B 2-binding alphaglobulin (Simons and Weber, 1966) , and there is enough evidence to indicate that white blood cells are a source of a low molecular weight protein, lysozyme (Barnes, 1940; Osserman and Lawlor, 1966) . However, the conclusion that an antidiuretic-hormonelike substance is released from the white cells is speculative, and further studies are required to prove it.
The presence of this syndrome in a high proportion of patients 55 with acute myeloid leukaemia is of great clinical importance. Water intoxication may produce confusion (Kaye, 1966) and disorientation (Weissman et al., 1971 )-symptoms which can readily be confused with the terminal state of acute leukaemia. Intravenous infusion can be hazardous inthese patients. Attention to the underlying electrolyte imbalance will lead to the correct diagnosis, which is reversible by water restriction.
